Arthritis drug restores full hair in severe alopecia patients in global trial

A global trial found that an arthritis drug achieved 100% hair regrowth in some patients with severe alopecia areata, an autoimmune condition. The treatment targets the underlying immune response rather than symptoms, marking a potential therapeutic breakthrough. Efficacy in a subset and long-term safety remain uncertain, but the result could shift standard care for a condition with few approved options.